MeiraGTx, a New York and London-based company, is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders.
We are pioneering the use of gene therapy to treat devastating neurodegenerative diseases such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). We are developing innovative gene therapies for ocular diseases including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx is also establishing treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers. Our revolutionary gene regulation technologies promise to transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.
Location: United States, New York
Total raised: $175M
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.08.2022 | - | $100M | Perceptive... |
| 24.07.2018 | IPO | $75M | - |
Mentions in press and media 13
| Date | Title | Description | Source |
| 09.03.2024 | OpenAI announces 'improvements' to its governance structure ... | Tech OpenAI announces 'improvements' to its governance structure nearly 5 months after Sam Altman's ... | businessin... |
| 21.12.2023 | MeiraGTx Announces Asset Purchase Agreement Involving its AA... | - | globenewsw... |
| 30.10.2023 | MeiraGTx Announces $30 Million Strategic Investment from San... | - | globenewsw... |
| 01.10.2022 | Late-Breaking Phase 1/2 Data Demonstrates Safety Profile of ... | LONDON and NEW YORK, Oct. 01, 2022 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc MGTX, a vertically inte... | einpresswi... |
| 16.09.2022 | MeiraGTx unveils bioscience manufacturing site in Shannon | Ireland’s first commercial-scale gene therapy manufacturing site, operated by MeiraGTx, was unveiled... | businesspl... |
| 03.08.2022 | MeiraGTx Announces Financing Agreement with Perceptive Advis... | - Credit facility is collateralized by MeiraGTx’s wholly-owned manufacturing facilities in London, U... | globenewsw... |
| 27.01.2022 | MeiraGTx Gets $30 Million Milestone Payment From Janssen Pha... | By Chris Wack MeiraGTx Holdings PLC said it received a $30 million payment from Janssen Pharmaceutic... | marketscre... |
| 24.07.2018 | UCL Technology Fund investment MeiraGTx raises $75m at IPO | UCL Technology Fund investment MeiraGTx Holdings plc (‘MeiraGTx’), the clinical stage gene therapy c... | ucltf.co.u... |
| 08.06.2018 | Term Sheet — Friday, June 8 | M&A OUTLOOK Good morning, Term Sheet readers. Paid Content You can't secure what you can't see F... | fortune.co... |
| 08.06.2018 | Ex-con Sam Waksal's startup prices IPO, joining parade o... | Biotechs are coming out of the woodwork this morning to set terms for their IPOs. So far, we’ve t... | endpts.com... |
Show more